Dental Sleep Medicine Conference, Dentist Dr. David Rawson, Toronto, Ontario, Canada – Video


Dental Sleep Medicine Conference, Dentist Dr. David Rawson, Toronto, Ontario, Canada
For more information, go to http://sleepbetter.tv/ Dr. David E Rawson of the TMJ and Sleep Therapy Centre of London, Ontario, discusses the Canadian Academy of Clinical Sleep Disorders Disciplines...

By: Sequence Media Group

Continue reading here:

Dental Sleep Medicine Conference, Dentist Dr. David Rawson, Toronto, Ontario, Canada - Video

New Tool Maps Family Medicine's Impact Around the World

Pushing through the daily practice grind, family physicians might not have a moment to consider that family medicine is happening not only across the country, but also around the world.

The AAFP's new World Health Mapper tool offers physicians a chance to easily do just that -- explore data on country-level health indicators, health care costs and capacity, vital statistics, and contacts for family medicine opportunities abroad.

Andrew Bazemore, M.D., M.P.H., director of the Robert Graham Center for Policy Studies in Family Medicine and Primary Care, told AAFP News that this application was developed using the Graham Center/AAFP online mapping platform, HealthLandscape.(www.healthlandscape.org)

"The project is a result of ambitions to expand our HealthLandscape geospatial data platform globally, while making global health data more available and readily accessible for primary care providers with global health interests," Bazemore said. "I've been active in global health education and activities for many years, and have wished many times for easily accessible international comparison data relevant to health and primary care."

Bazemore added that the tool offers a snapshot of the status and spread of family medicine around the globe, enhanced with contextual information about health and health care in the countries where family medicine currently is being practiced or potentially could be someday.

The global mapping project was born in early 2014, when an opportunity presented itself to combine a HealthLandscape data visualization tool with primary data collection by Graham Center Fellow John Parks, M.D. The tool was built in 10 months without external funding.

Mark Carrozza and Jene Grandmont at HealthLandscape gathered and adapted the World Bank's World Development Indicators data catalog, as well as health data from the Organisation for Economic Co-operation and Development, and created an online visualization tool using HealthLandscape's existing platform.

Parks (currently working in Malawi) and a team of students gathered information on the status of family medicine in nearly every country in the world, Bazemore said. Alexander Ivanov, director of the AAFP Center for Global Health Initiatives, and Julie Wood, M.D., AAFP vice president of health of the public and science and interprofessional activities, supported the effort by disseminating the information and getting it integrated into the AAFP website.

Bazemore recommended interested family physicians start using the tool by selecting the "Global Family Medicine Project" button to view information on where family medicine training is happening, which countries' ministries of health or education have recognized family medicine, and where related family medicine organizations are located.

"Click on other national characteristics to see how the presence or absence of family medicine is associated with national health care costs, disease rates and demographics," Bazemore added.

Original post:

New Tool Maps Family Medicine's Impact Around the World

Nanomedicine shines light on combined force of nanomedicine and regenerative medicine

IMAGE:This is the cover of Nanomedicine, MEDLINE indexed Impact factor: 5.824 (2013). view more

Credit: Future Science Group

31 March, 2015 - Nanomedicine has published a special focus issue on the combined force of nanomedicine and regenerative medicine; two fields that continue to develop at a dramatic pace.

Titled 'Engineering the nanoenvironment for regenerative medicine', the issue is guest edited by Professor Matthew J. Dalby (University of Glasgow, UK, and associate editor of Nanomedicine) and Dr Manus J.P. Biggs (National University of Ireland, Galway, Ireland). It comprises 9 primary research articles and 3 reviews covering topics relevant to the current translation of nanotopography and nanofunctionalization for nanoscale regenerative strategies in medicine.

Indeed, the field of 'nanoregeneration' has grown exponentially over the last 15 years, and fields of study focusing on the nanobiointerface now include nanotopographical modification, formulation of existing biomaterials and modification of the extracellular matrix, as well as the development of targeting techniques using nanoparticles.

Nanoscale platforms are becoming increasingly recognized as tools to understand biological molecules, subcellular structures and how cells and organs work. Therefore, they could have real applications in regenerative medicine and increase our knowledge of how stem cells work, or in drug discovery and cell targeting.

"The fields of nanomedicine and regenerative medicine continue to evolve at a dramatic pace, with new and exciting developments almost a daily occurrence. This special focus issue highlights the translational research, reviews current thinking and 'shines a light' on the future potential of a field where nanomedicine converges with regenerative medicine," said Michael Dowdall, Managing Commissioning Editor of Nanomedicine. "We feel this is an important subject for our readers to have a comprehensive and contextual overview of. The special focus issue helps provide this context for researchers, by framing the potential applications of nanomedicine/nanoengineering in terms of the current 'state of the art' regenerative medicine techniques."

Professor Dalby commented: "This special focus issue on nanoscale regenerative strategies focuses on basic and translational aspects of nanotopography and nanofunctionalization, and also gives perspective to future fundamental developments in the field, helping provide a future translational pipeline."

Members of RegMedNet, the online community for those working in the field of regenerative medicine, can access select articles from the special focus issue through the online platform.

###

Read more here:

Nanomedicine shines light on combined force of nanomedicine and regenerative medicine

A doctor gives an injection of medicine for a drug addict. Free HD video footage – Video


A doctor gives an injection of medicine for a drug addict. Free HD video footage
A wrist is hold out for a doctor to give an injection of medicine. A squirt is used by a physician to stick into blood vessel on a carpus. A drug addict or any other patient is waiting for...

By: Unripe Content

Go here to read the rest:

A doctor gives an injection of medicine for a drug addict. Free HD video footage - Video

Survival Medicine for prepping discussion with Prime Medical Training – Video


Survival Medicine for prepping discussion with Prime Medical Training
In this video Andrew from Prime medical visits with me to discuss and demonstrate things that could be life saving in a survival situation. Andrew will also be at the mountain preppers expo...

By: 7 TRUMPETS PREPPER

Original post:

Survival Medicine for prepping discussion with Prime Medical Training - Video

Odds of reversing ICU patients' preferences to forgo life-sustaining care vary, Penn study finds

PHILADELPHIA -- Intensive care units across the United States vary widely in how they manage the care of patients who have set preexisting limits on life-sustaining therapies, such as authorizing do-not-resuscitate (DNR) orders and prohibiting interventions such as feeding tubes or dialysis, according to new research from the Perelman School of Medicine at the University of Pennsylvania. Their work is published in the current issue of JAMA Internal Medicine.

"We've long known that end-of-life and critical care varies across nations, regions and centers, whether from changes in local policies, practice culture or resource constraints," said the study's lead author Joanna L. Hart, MD, MSHP, a pulmonary and critical care physician and post-doctoral research fellow at Penn. "But, we hypothesized that by looking at this specific patient population, we could attribute this variability as an appropriate response to patient preferences in care, and undue or unsupported variability. No previous studies we're aware of have analyzed variations in care for patients who, upon admission, have similar care requests."

Hart and colleagues also sought to determine the portion of ICU patients who are admitted with existing treatment limitations - which may have been outlined in advance directives or otherwise ordered by inpatient physician -- and how these patients are managed in the ICU.

The researchers examined a retrospective cohort of patients from 141 intensive care units in 105 hospitals, for a total of 277,693 patients from April 2001 through December 2008 and found that 4.8 percent of ICU admissions were patients with preexisting limits on care. Care limitations for most of these patients included DNR orders, which included preferences prohibiting chest compressions, intubation and use of defibrillation to restart their hearts. Other patients had documented restrictions on acceptable therapies, ranging from dialysis to nutritional support such as feeding tubes (21 percent), and four percent expressed a preference for comfort measures only. Patients admitted with treatment limitations tended to be older than those without such limits (78 years on average) and nearly all had preexisting chronic illnesses conditions, most commonly chronic respiratory disease (14 percent) and chronic kidney disease (13 percent). Most (52 percent) of patients were admitted to the ICU from the emergency department, and 35 percent died during the hospital stay studied.

But the researchers found that these patients' preferences to refrain from use of lifesaving measures were often changed during their stay. Among all patients admitted with treatment limitations, 23 percent of patients nonetheless received CPR in the ICU, with great variability among ICUs: with less than five percent of patients at some ICUs and greater than 90 percent in other ICUs. Overall, 41 percent of patients who entered with treatment limitations received one or more forms of life support, and 18 percent had a reversal of previous treatment limitations during their ICU stay.

The researchers found that when ICU care was managed by a critical care physician, the odds were greater that the preexisting limitations on care would change and their care would be escalated with new forms of life support administered. Suburban hospitals, when compared to urban settings, were found to be associated with greater odds that patients surviving an ICU stay would receive new treatments and have new treatment limitations established during their stay.

"The variability here is astounding and no matter how hard we tried, we could not make it go away by accounting for any differences among the patients admitted to different ICUs," says the study's senior author, Scott Halpern, MD, PhD, MBE, assistant professor of Medicine, Epidemiology, and Medical Ethics and Health Policy. "Surprisingly, for patients who had already outlined 'I don't want this or that procedure or treatment at end of life,' escalations of treatment intensity were nonetheless more common than de-escalations," said Halpern. "This tendency toward aggressiveness varies widely depending only on which ICU a patient happens to be admitted to. There seems to be great potential for better aligning the outcomes of critical care with the outcomes people desire through a better understanding of how treatment decisions are made for patients who can and cannot communicate their preferences. We suggest that having clear, effective advance directives along with accompanying conversations with potential surrogate decision makers (usually family) is the best way to prevent unwanted care during an ICU stay."

###

Penn Medicine is one of the world's leading academic medical centers, dedicated to the related missions of medical education, biomedical research, and excellence in patient care. Penn Medicine consists of the Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania (founded in 1765 as the nation's first medical school) and the University of Pennsylvania Health System, which together form a $4.9 billion enterprise.

The Perelman School of Medicine has been ranked among the top five medical schools in the United States for the past 17 years, according to U.S. News & World Report's survey of research-oriented medical schools. The School is consistently among the nation's top recipients of funding from the National Institutes of Health, with $409 million awarded in the 2014 fiscal year.

See the original post here:

Odds of reversing ICU patients' preferences to forgo life-sustaining care vary, Penn study finds